- 1. Drug
- [biologically active substance, including those intended for use in diagnosis, treatment, or prevention of disease or other abnormalities, for the relief of suffering, or control or improvement of a physical or mental state; includes biological products. ( CSP )] (UMLS (NCI) C0013227) =Pharmacologic Substance =Chemical;
National Drug File - Reference Terminology;
Pharmacy Order Types;
=abortifacient;
inhibitor/antagonist;
[MS100] ANTIRHEUMATICS;
antiinfective agent;
antiinflammatory agent;
antidote;
antimetabolite;
[AN000] ANTINEOPLASTICS;
Biological Agent;
Cancer Causing Agents;
[CV000] CARDIOVASCULAR MEDICATIONS;
More… | - 51. Drug dependence, postpartum
- [ ] (UMLS (ICD9CM) C0156853) =Mental or Behavioral Dysfunction
|
- 2. drug (biosynthesized)
- [ ] (UMLS (CSP) C0597994) =Pharmacologic Substance ;
| - 52. drug design
- [The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include pharmacokinetics, dosage analysis, or drug administration analysis. ( MSH )] (UMLS (CSP) C0013171) =Occupation or Discipline
|
- 3. drug abstinence
- [ ] (UMLS (CSP) C0237443) =Individual Behavior ;
| - 53. drug design/synthesis/production
- [drug (or potential drug) synthesis or development; includes production of drugs, hormones, and related chemicals; some projects may include DRUG DISCOVERY/ISOLATION; for development of non-drug substances such as radiotracers see TECHNOLOGY/TECHNIQUE DEVELOPMENT. ( CSP )] (UMLS (CSP) C0178604) =Phenomenon or Process =biomedical resource;
technology/technique development =drug screening/evaluation;
orphan disease/drug;
drug quality/standard;
drug discovery/isolation;
|
- 4. Drug abuse
- [excessive use of drugs or chemicals with associated psychological symptoms and impairment in social or occupational functioning.(CSP)] (UMLS (ICPC) C0013146) (Drug abuse; DROGA ABUSUA; Stofmisbrug; Drugs misbruik; HUUMEIDEN KAYTTO; Toxicomanie; Drogenmissbrauch; narkoman; drog abusus; Abuso di droghe; STOFFMISBRUK; Abuso de droga; Abuso de drogas; DROGMISSBRUK) =Mental or Behavioral Dysfunction ;
=Symptoms and Complaints Component; PSYCHOLOGICAL; substance abuse related disorder; =marijuana abuse; intravenous drug abuse; inhalation drug abuse | - 54. drug detection
- [procedures to detect the presence of drugs or their side products in blood, urine, breath, or other biological samples; do not confuse with DRUG SCREENING/EVALUATION. ( CSP )] (UMLS (CSP) C0038577) =Laboratory Procedure ;
=drug control;
evaluation/testing |
- 5. drug abuse chemotherapy
- [application of the beneficial effects of drugs to control or cure drug abuse (the excessive use of drugs or chemicals with associated psychological symptoms and impairment in social or occupational functioning). ( CSP )] (UMLS (CSP) C0596459) =Therapeutic or Preventive Procedure =chemotherapy;
drug abuse therapy | - 55. DRUG DETOXIFICATION
- [ ] (UMLS (ICD9CM) C0204600) =Therapeutic or Preventive Procedure
|
- 6. drug abuse education
- [instruction or training that encourages behaviors most likely to optimize health potentials through information about drug abuse; facilitates the prevention of drug abuse, frequently for those who are at risk; also includes instruction or training that increases the awareness and favorably influences the attitudes and knowledge about drug abuse on a personal or community basis; it also includes the training of medical personnel about drug abuse for prevention or treatment programs, for this type of drug abuse education postcoordinate with the appropriate health professional education term; this concept may overlap with DRUG ABUSE PREVENTION. ( CSP )] (UMLS (CSP) C0596460) =Educational Activity =health education;
drug abuse prevention =tobacco abuse education;
alcohol abuse education;
| - 56. drug development
- [Design, identification, synthesis, extraction, purification, modification, or characterization of potential anticancer agents; studies of their metabolism, distribution, excretion, physiological effects, molecular interactions, structural analysis, toxicity, mechanism of action, antitumor effects in vivo (nonhuman species) or in vitro (human or nonhuman), and phase I and phase II clinical trials. ( NCI )] (UMLS (CSP) C0872152) =Biomedical Occupation or Discipline ;
|
- 7. drug abuse information system
- [integrated set of files, procedures, and equipment for the storage, manipulation, and retrieval of information on drugs of abuse; also used to cover the concept of drug abuse databases. ( CSP )] (UMLS (CSP) C0596461) =Intellectual Product =information system;
| - 57. drug discovery
- [ ] (UMLS (CSP) C0920472) =Research Activity
|
- 8. DRUG ABUSE NEC-CONTIN
- [ ] (UMLS (ICD9CM) C0154545) =Mental or Behavioral Dysfunction
| - 58. drug discovery/isolation
- [identification of naturally-derived or synthetic compounds with therapeutic potential. ( CSP )] (UMLS (CSP) C0872033) =Research Activity ;
=drug design/synthesis/production;
|
- 9. DRUG ABUSE NEC-EPISODIC
- [ ] (UMLS (ICD9CM) C0154546) =Mental or Behavioral Dysfunction
| - 59. drug discrimination
- [ ] (UMLS (CSP) C0679080) =Idea or Concept ;
|
- 10. DRUG ABUSE NEC-IN REMISS
- [ ] (UMLS (ICD9CM) C0154547) =Mental or Behavioral Dysfunction
| - 60. drug efficacy
- [ ] (UMLS (CSP) C0598333) =Qualitative Concept
|
- 11. DRUG ABUSE NEC-UNSPEC
- [ ] (UMLS (ICD9CM) C0154544) =Mental or Behavioral Dysfunction
| - 61. Drug Enforcement Administration registration number
- (UMLS (HL7) C1549689) =Intellectual Product =Identifier type;
|
- 12. drug abuse prevention
- [increasing the awareness of drug abuse, prevention of drug abuse in susceptible individuals or populations through promotion of health, including mental health, or with chemopreventive methods, and prevention of complications or after-effects of existing disease; this concept may overlap with DRUG ABUSE EDUCATION. ( CSP )] (UMLS (CSP) C1171189) drug addiction prevention =Therapeutic or Preventive Procedure ;
=disease/disorder prevention/control;
mental disorder prevention =alcoholism/alcohol abuse prevention;
drug abuse education;
| - 62. Drug Enforcement Agency
- (UMLS (HL7) C1549052) =Organization =Organization, agency, department;
|
- 13. drug abuse related behavior
- [ ] (UMLS (CSP) C0872151) =Individual Behavior ;
| - 63. Drug Enforcement Agency no.
- (UMLS (HL7) C1548637) =Intellectual Product =Practitioner ID number type;
|
- 14. drug abuse therapy
- [treatments alone or in combination for drug abuse or addiction or related disorders; including but not limited to, chemotherapy, behavioral therapy, psychotherapy, aversion therapy, alternative medicine, group counseling. ( CSP )] (UMLS (CSP) C0418979) =Therapeutic or Preventive Procedure =Therapeutic Interventions;
=smoking cessation;
drug abuse chemotherapy | - 64. drug evaluation
- [Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. ( MSH )] (UMLS (CSP) C0013175) =Research Activity
|
- 15. drug action
- [ ] (UMLS (CSP) C0728867) =Pathologic Function ;
| - 65. Drug Excipient
- [Any intentionally added component of a finished pharmaceutical product other than the claimed therapeutic or diagnostic ingredient(s). The excipients are added to facilitate administration or manufacture, improve product delivery, promote the consistent release and bioavailability of the drug, enhance stability, assist in product identification, or enhance other product characteristics. Pharmaceutical excipients do not affect therapeutic effects of the preparation or suitable tests or assays. The term does not apply to macromolecular compounds like albumin, or compounds like amino acids and sugars that are used in biological products, nor does it apply to process or product-related impurities (e.g. degradation products, residual solvents), or extraneous contaminants. ( NCI )] (UMLS (NCI) C0015237) =Biomedical or Dental Material ;
|
- 16. DRUG ADDICT COUNSELLING
- (UMLS (ICD9CM) C0199403) =Therapeutic or Preventive Procedure
| - 66. Drug Exposure
- [The term describes the situation in which a constant drug dose elicits increasing effects.The condition is opposite to drug tolerance since less dose of the substance is required to reinstate the initial effect (reverse-tolerance). The concept does not refer to cumulative drug effect. ( NCI )] (UMLS (NCI) C0743284) =Finding ;
|
- 17. drug addiction antagonist
- [any agent used as a drug addiction deterrent, by blocking addictive effects, causing unpleasant symptoms when drugs are ingested, or as aids in withdrawal or maintenance of abstinence. ( CSP )] (UMLS (CSP) C0596462) =Pharmacologic Substance =inhibitor/antagonist;
=Narcotic Antagonist | - 67. Drug Extravasation
- [Leakage of drug from a vein into the surrounding tissue. ( NCI )] (UMLS (NCI) C0280952) =Injury or Poisoning
|
- 18. drug addiction chemotherapy
- [ ] (UMLS (CSP) C0598325) =Therapeutic or Preventive Procedure
| - 68. drug extravasation management
- (UMLS (NCI) C0280283) =Therapeutic or Preventive Procedure
|
- 19. drug addiction pharmacotherapy
- [ ] (UMLS (CSP) C1328873) =Therapeutic or Preventive Procedure; ;
| - 69. Drug Formulation
- [The act or process of developing or preparing a mixture of ingredients to create a desired end drug product, such as a specific flavor, aroma, or polymer; or the desired final drug product itself; also, a listing of the ingredients and composition of the dosage form. ( NCI )] (UMLS (NCI) C0524527) =Research Activity
|
- 20. drug addiction therapy
- [ ] (UMLS (CSP) C0700570) =Therapeutic or Preventive Procedure ;
| - 70. Drug Furnishing or prescriptive authority Number
- (UMLS (HL7) C1549690) =Intellectual Product =Identifier type;
|
- 21. drug administration duration
- [ ] (UMLS (CSP) C0920470) =Quantitative Concept
| - 71. drug habituation
- [process whereby an individual's response to a drug lessens with repeated use. ( CSP )] (UMLS (CSP) C0013170) =Mental or Behavioral Dysfunction =behavioral habituation/sensitization;
substance abuse related disorder |
- 22. drug administration rate
- [ ] (UMLS (CSP) C0920471) =Quantitative Concept
| - 72. drug induced behavior
- [ ] (UMLS (CSP) C0872153) =Individual Behavior ;
|
- 23. drug administration rate/duration
- [time schedule for the administration of a drug, rate of drug use or course of administration of drugs. ( CSP )] (UMLS (CSP) C0684252) =Quantitative Concept ;
= ;
| - 73. drug induced congenital disorder
- [ ] (UMLS (CSP) C0870452) drug related congenital disorder =Congenital Abnormality; Disease or Syndrome
|
- 24. drug administration route
- [various ways of administering a drug or other chemical to a site in a patient or animal from where the chemical is absorbed and delivered to the target tissue. ( CSP )] (UMLS (CSP) C0013153) =Functional Concept ;
=Pharmacologic;
HL7 Vocabulary Version 2.5 =inhalation drug administration;
oral administration;
topical drug administration;
perfusion;
smoking;
DDS;
injection/infusion;
subcutaneous drug administration;
SL;
perfusion;
Cutaneous Route of Administration;
Subcutaneous;
Intrathecal;
Oral;
INH;
Intranasal;
EPIDUR;
Apply Externally;
Endotrachial Tube*;
GU Irrigant;
Immerse (Soak) Body Part;
Intracervical (uterus);
Nasogastric;
Nasotrachial Tube;
Other/Miscellaneous;
Rebreather Mask*;
Soaked Dressing;
Translingual;
Ventimask;
Intrahepatic Artery;
Intrasynovial;
Mouth/Throat;
Tracheostomy*;
Nasal;
T;
Dental;
BUCC;
Auricular;
I-BURSAL;
I-CARDI;
Intraocular;
Intrauterine;
OPHTH;
DL;
Intraurethral Route of Administration;
VAG;
Intraperitoneal;
Intravenous;
Per Rectum;
Gastrostomy Tube;
Mucous Membrane;
Nasal Prongs*;
Wound;
Intramuscular;
Intra-arterial | - 74. drug induced lupus
- [ ] (UMLS (CSP) C0263591) =Disease or Syndrome
|
- 25. drug adulteration
- [The addition of less desirable substance to the drug preparation. ( MSH )] (UMLS (CSP) C0013155) =Human-caused Phenomenon or Process ;
| - 75. DRUG INDUCED MYOTONIA
- [ ] (UMLS (ICD9CM) C1404542) Drug-induced myotonia;
=Pathologic Function ;
|
- 26. drug adverse effect
- [unintended, deleterious effects of otherwise licit, therapeutic, properly administered drugs; for effects of illicit and abused drugs, or of environmental chemicals, see TOXICOLOGY or POISONING. ( CSP )] (UMLS (CSP) C0041755) =Injury or Poisoning =Pharmacologic;
side effect =drug related diabetes mellitus;
embryo/fetus drug adverse effect;
drug related neoplasm/cancer | - 76. DRUG INDUCED NEUTROPENIA
- [ ] (UMLS (ICD9CM) C0272178) =Disease or Syndrome
|
- 27. drug allergen
- [ ] (UMLS (CSP) C1320237) =Immunologic Factor; ;
| - 77. DRUG INDUCED SLEEP DISOR
- [ ] (UMLS (ICD9CM) C1456292) Drug induced sleep disorders;
=Mental or Behavioral Dysfunction |
- 28. drug allergy
- [immunologically mediated adverse reactions to medicinal substances used legally or illegally. ( CSP )] (UMLS (CSP) C0013182) =Disease or Syndrome =Allergic Reaction;
drug intolerance =dermatitis medicamentosa | - 78. drug information system
- [Information systems, usually computer-assisted, designed to store, manipulate, and retrieve information for planning, organizing, directing, and controlling administrative activities associated with the provision and utilization of clinical pharmacy services. ( MSH )] (UMLS (CSP) C0079133) =Manufactured Object; Intellectual Product ;
|
- 29. Drug allergy
- (UMLS (HL7) C1548333) =Immunologic Factor =Allergen Type;
| - 79. drug interaction
- [physical chemical interaction between drugs and other compounds, including other drugs, particularly in biological systems. ( CSP )] (UMLS (CSP) C0687133) =Molecular Function =physical chemical interaction;
=nutrient drug interaction |
- 30. DRUG ALLERGY NEC
- (UMLS (ICD9CM) C1719669) Other drug allergy =Disease or Syndrome
| - 80. Drug Interaction Alert
- [Proposed therapy may interact with an existing or recent drug therapy ( HL7V3.0 )] (UMLS (HL7) C1553528) =Intellectual Product =Therapeutic Product Alert;
|
- 31. drug biological activity
- [ ] (UMLS (CSP) C0599112) =Functional Concept
| - 81. Drug interference
- (UMLS (HL7) C1547774) =Idea or Concept =HL7 Vocabulary Version 2.5;
|
- 32. drug biological half life
- [ ] (UMLS (CSP) C0599113) =Temporal Concept
| - 82. drug intolerance
- [Hypersensitivity resulting in an adverse reaction upon exposure to a drug. ( HL7V3.0 )] (UMLS (CSP) C0277585) =Pathologic Function =intolerance;
=drug allergy;
Drug Non-Allergy Intolerance;
|
- 33. drug carcinogenesis
- [process by which normal cells are transformed into cancer cells by means of a drug. ( CSP )] (UMLS (CSP) C0596466) =Neoplastic Process =Cancer Induction;
| - 83. drug intolerant
- [ ] (UMLS (CSP) C0599741) =Finding ;
|
- 34. drug classification
- [systematic arrangement of drugs into categories or classes based on common characteristics such as properties, structure, function, usage, etc. ( CSP )] (UMLS (CSP) C0596463) =Intellectual Product =Pharmacologic;
classification | - 84. drug invoice group
- [A grouping of invoice element details including the one specifying the drug being invoiced. It may also contain generic detail items such as markup. ( HL7V3.0 )] (UMLS (HL7) C1555661) =Intellectual Product =ActInvoiceInterGroupCode;
|
- 35. drug clearance
- [ ] (UMLS (CSP) C0683151) =Physiologic Function ;
| - 85. drug isolation
- [ ] (UMLS (CSP) C0920473) =Research Activity
|
- 36. Drug Company
- [A company licensed to discover, develop, market and distribute drugs. ( NCI )] (UMLS (NCI) C0815266) Pharmaceutical Company;
=Health Care Related Organization ;
| - 86. drug legislation
- [Laws concerned with manufacturing, dispensing, and marketing of drugs. ( MSH )] (UMLS (CSP) C0023255) =Regulation or Law
|
- 37. drug control
- [control of drug and narcotic use by international agreement, or by institutional systems for handling prescribed drugs; includes regulations concerned with the manufacturing, dispensing, approval, and marketing of drugs. ( CSP )] (UMLS (CSP) C0013168) =Governmental or Regulatory Activity =legal/correctional;
=drug detection | - 87. drug leukemogenesis
- [ ] (UMLS (CSP) C0598329) =Neoplastic Process
|
- 38. drug craving
- [ ] (UMLS (CSP) C0556446) =Finding
| - 88. drug maintenance
- [ ] (UMLS (CSP) C0598144) =Therapeutic or Preventive Procedure ;
|
- 39. DRUG DEPEND NEC-CONTIN
- [ ] (UMLS (ICD9CM) C0338738) =Mental or Behavioral Dysfunction
| - 89. drug mechanism
- [ ] (UMLS (CSP) C0920474) =Pathologic Function
|
- 40. DRUG DEPEND NEC-EPISODIC
- [ ] (UMLS (ICD9CM) C0338739) =Mental or Behavioral Dysfunction
| - 90. DRUG MENTAL DISORDER NEC
- [ ] (UMLS (ICD9CM) C0154325) =Mental or Behavioral Dysfunction
|
- 41. DRUG DEPEND NEC-IN REM
- [ ] (UMLS (ICD9CM) C0154500) =Mental or Behavioral Dysfunction
| - 91. DRUG MENTAL DISORDER NOS
- [ ] (UMLS (ICD9CM) C0154330) =Mental or Behavioral Dysfunction
|
- 42. DRUG DEPEND NEC-UNSPEC
- [ ] (UMLS (ICD9CM) C0029792) =Mental or Behavioral Dysfunction ;
| - 92. drug metabolism
- [the buildup and breakdown of drugs for utilization by the organism. ( CSP )] (UMLS (CSP) C0683140) =Molecular Function ;
=Intermediary Metabolism;
mechanism of action |
- 43. DRUG DEPEND NOS-CONTIN
- [ ] (UMLS (ICD9CM) C0154509) =Mental or Behavioral Dysfunction
| - 93. drug modification
- [ ] (UMLS (CSP) C0598331) =Biomedical Occupation or Discipline
|
- 44. DRUG DEPEND NOS-EPISODIC
- [ ] (UMLS (ICD9CM) C0154510) =Mental or Behavioral Dysfunction
| - 94. Drug Modulation
- (UMLS (NCI) C0279532) =Therapeutic or Preventive Procedure
|
- 45. DRUG DEPEND NOS-REMISS
- [ ] (UMLS (ICD9CM) C0154511) =Mental or Behavioral Dysfunction
| - 95. Drug Non-Allergy Intolerance
- [Hypersensitivity to an agent caused by a mechanism other than an immunologic response to an initial exposure ( HL7V3.0 )] (UMLS (HL7) C1699571) =Clinical Attribute ;
=drug intolerance;
Non-Allergy Intolerance |
- 46. DRUG DEPEND NOS-UNSPEC
- [ ] (UMLS (ICD9CM) C0375178) =Mental or Behavioral Dysfunction
| - 96. DRUG PERSIST AMNESTC DIS
- [ ] (UMLS (ICD9CM) C1456289) Drug-induced persisting amnestic disorder;
=Disease or Syndrome |
- 47. DRUG DEPEND PREG-UNSPEC
- [ ] (UMLS (ICD9CM) C0269685) =Mental or Behavioral Dysfunction
| - 97. DRUG PERSISTING DEMENTIA
- [ ] (UMLS (ICD9CM) C1456288) Drug-induced persisting dementia;
=Mental or Behavioral Dysfunction |
- 48. Drug dependence of mother, with delivery
- [ ] (UMLS (ICD9CM) C0156850) =Mental or Behavioral Dysfunction
| - 98. drug preservation
- [preventing drugs or pharmaceuticals from decay, separation, being rendered useless, or extending the shelf life of drugs by means of a chemical agent, cooling, or other physical process. ( CSP )] (UMLS (CSP) C0728909) =Laboratory Procedure =preservation;
|
- 49. Drug dependence of mother, with delivery, with mention of postpartum complication
- [ ] (UMLS (ICD9CM) C0156851) =Mental or Behavioral Dysfunction
| - 99. Drug Preservative
- [Chemicals that are added to drug products to prolong shelf life and maintain sterility. Protection of formulations, especially aqueous solutions, against microbial growth requires use of either antibacterial or antifungal preservatives. Generally, such agents are active against either bacteria or fungi but a few are active against both. The antimicrobials include but not limited to chlorobutanol, benzyl alcohol, sodium benzoate, sorbic acid, and phenol. The antioxidizing agents include butylated hydroxytolune, hydroxyanisole, propyl gallate, and sulfites. The necessary addition of preservatives for both safety and economy sometimes has been associated with significant adverse effects in certain patient populations. ( NCI )] (UMLS (NCI) C0033086) =Biomedical or Dental Material ;
=inactive ingredient;
|
- 50. Drug dependence, antepartum
- [ ] (UMLS (ICD9CM) C0156852) =Mental or Behavioral Dysfunction
| - 100. drug production
- [ ] (UMLS (CSP) C0920698) =Biomedical Occupation or Discipline
|
home
